OMNARIS drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.
There are no data available on the effects of acute or chronic overdosage with OMNARIS Nasal Spray. Because of low systemic bioavailability, acute overdosage is unlikely to require any therapy other than observation. A single oral dose of up to 10 mg of ciclesonide in healthy volunteers was well tolerated and serum cortisol levels were virtually unchanged in comparison with placebo treatment. Chronic overdosage with any corticosteroid may result in signs or symptoms of hypercorticism (See PRECAUTIONS).
OMNARIS Nasal Spray is contraindicated in patients with a hypersensitivity to any of its ingredients.